DHR vs KO: Which Is the Better Buy?
Side-by-side comparison of Danaher Corporation and The Coca-Cola Company — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-23.
Danaher Corporation · Healthcare
$221.12
+29.6% upside to fair value
Med Conviction
Grade B
High Quality
VS
The Coca-Cola Company · Consumer Defensive
$88.71
+15.5% upside to fair value
Med Conviction
Grade C
High Quality
QuantHub Verdict
DHR has more upside to fair value
(+29.6%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
DHR |
KO |
| Current Price |
$221.12 |
$88.71 |
| Fair Value Estimate |
$286.52 |
$102.44 |
| Upside to Fair Value |
+29.6%
|
+15.5%
|
| Market Cap |
$155.4B |
$381.7B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
24.8x
|
20.8x
|
| Price / Sales |
6.2x
|
7.6x
|
| Price / FCF |
28.5x
|
26.7x
|
| Revenue Growth YoY |
+5.5%
|
+6.7%
|
| Gross Margin |
58.5%
|
61.9%
|
| Operating Margin |
20.4%
|
29.6%
|
| Return on Equity |
7.7%
|
43.0%
|
| Dividend Yield |
0.65% |
2.37% |
| FCF Yield |
3.51%
|
3.75%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
Danaher is a diversified life-sciences and diagnostics platform spanning three segments: Life Sciences (mass spectrometers, flow cytometry, genomics, bioprocess technologies), Diagnostics (chemistry, immunoassay, microbiology, hematology, molecular and pathology systems), and Environmental & Applied Solutions (water quality and product-identification instrumentation). The business quality is high…
The Coca-Cola Company is a global non-alcoholic beverage concentrate, brand-management and bottling-system business with products sold in more than 200 countries and territories, supported by powerful trademarks, 2.2 billion daily servings and an entrenched distribution network. Business quality is high: TTM gross, operating and net margins are 61.9%, 29.6% and 28.6%, respectively, ROE is 43.0%, …
Accumulation Zones
| Metric |
DHR |
KO |
| Zone Low |
$214.89 |
$76.83 |
| Zone High |
$243.54 |
$87.07 |
| In Buy Zone? |
Yes
|
No
|